Edera is a cybersecurity company that specializes in robust workload isolation solutions for Kubernetes and AI environments. Its core technology, a cloud-native Type 1 hypervisor, ensures each container operates within its own isolated kernel, preventing lateral movement and eliminating container escapes. This approach enhances security without compromising performance. Edera's platform is designed for seamless integration, requiring minimal configuration to secure workloads across various infrastructures. Additionally, the company supports open-source initiatives, such as 'Am I Isolated,' a Rust-based container runtime scanner that detects gaps in container isolation.
Enveda Biosciences
Series C in 2024
Enveda Biosciences is a biotechnology company that employs artificial intelligence-powered tools to investigate and define molecules sourced from living organisms. Its primary objective is to build an exhaustive database of chemical biodiversity, thereby expediting the discovery of novel medicines. The company's innovative drug discovery platform integrates machine learning, metabolomics, and robotics to analyze natural samples for both chemical structure and biological activity, eliminating the need for isolating individual compounds or extensive experimentation. This enables healthcare industry clients to develop a wide range of new medications, from antibiotics to hypotensives.
Edera is a cybersecurity company that specializes in robust workload isolation solutions for Kubernetes and AI environments. Its core technology, a cloud-native Type 1 hypervisor, ensures each container operates within its own isolated kernel, preventing lateral movement and eliminating container escapes. This approach enhances security without compromising performance. Edera's platform is designed for seamless integration, requiring minimal configuration to secure workloads across various infrastructures. Additionally, the company supports open-source initiatives, such as 'Am I Isolated,' a Rust-based container runtime scanner that detects gaps in container isolation.
Credo AI is a company focused on enabling enterprises to responsibly develop, adopt, and utilize artificial intelligence at scale. Founded in 2020, it offers a sophisticated AI governance platform that automates oversight and risk management associated with AI technologies. This platform ensures continuous regulatory compliance with emerging global standards, including the EU AI Act and guidelines from NIST and ISO. By providing tools to measure, monitor, and manage risks linked to AI implementations, Credo AI helps businesses build customer trust, differentiate their offerings, and effectively manage potential challenges. The company has garnered recognition for its innovation, being listed among the CBInsights AI 100 and named a Technology Pioneer by the World Economic Forum, among other accolades.
Vectara is a developer of a generative AI product platform that enables businesses to integrate advanced AI features into their applications. The company offers an end-to-end serverless Retrieval Augmented Generation (RAG) API platform, which provides a secure and efficient way to incorporate conversational AI and question-answering capabilities. Vectara's platform is built on a hybrid-search core, ensuring accurate and reliable results that are grounded in the specific data and knowledge of the organization. It addresses critical challenges associated with enterprise adoption, such as reducing hallucination, enhancing explainability, enforcing access control, and allowing for real-time updates of knowledge. Additionally, Vectara's platform supports multilingual capabilities and prioritizes data security, making it suitable for various applications including semantic search, research analysis, and conversational AI, thus enabling organizations to create experiences similar to ChatGPT.
Formation Bio
Series D in 2024
Formation Bio is a biotechnology company dedicated to accelerating drug development and enhancing patient access to new treatments by reimagining clinical trials. The company has developed a platform that scales a network of clinical trial sites integrated within existing medical practices. By utilizing a roaming cohort of certified research coordinators and leveraging advanced software and data analytics, Formation Bio enables researchers to optimize their access to human subjects for various studies, including clinical trials and psychological research. This innovative approach aims to streamline the clinical trial process, ultimately facilitating faster delivery of new therapies to patients.
Enveda Biosciences
Series B in 2024
Enveda Biosciences is a biotechnology company that employs artificial intelligence-powered tools to investigate and define molecules sourced from living organisms. Its primary objective is to build an exhaustive database of chemical biodiversity, thereby expediting the discovery of novel medicines. The company's innovative drug discovery platform integrates machine learning, metabolomics, and robotics to analyze natural samples for both chemical structure and biological activity, eliminating the need for isolating individual compounds or extensive experimentation. This enables healthcare industry clients to develop a wide range of new medications, from antibiotics to hypotensives.
Astra, Inc., established in 2016 and based in Menlo Park, California, specializes in budgeting automation. Its platform connects to users' bank accounts, providing personalized financial recommendations and enabling automated money transfers or notifications based on user-defined rules and triggers.
HumanX focuses on AI serves as a catalyst for enterprises to identify realistic solutions in the rapidly changing AI field.
Reken is an AI and cybersecurity firm established in 2024 and headquartered in San Francisco, California. The company is focused on developing innovative cybersecurity solutions designed to combat threats arising from generative AI, such as deepfake social engineering and automated fraud. Reken's platform aims to create a new category of AI products that employs a layered defense strategy. This approach combines zero trust principles with technological analysis of content, allowing users to effectively identify and mitigate malicious activities. Through its advancements, Reken seeks to enhance the security landscape in response to evolving digital threats.
Charlie is the new standard for 62+ banking* services. Charlie helps retirees make the most of their limited resources with features including faster access to their Social Security check, competitive earnings on deposits, no monthly fees or minimums, US-based customer service, and a simple, transparent digital experience designed for their needs. Charlie is transforming financial assistance for the 62+ community and providing peace of mind around their financial present and future. Charlie is not a bank, banking services provided by Sutton Bank; Member FDIC. To learn more, visit Charlie.com.
Charlie
Debt Financing in 2023
Charlie is the new standard for 62+ banking* services. Charlie helps retirees make the most of their limited resources with features including faster access to their Social Security check, competitive earnings on deposits, no monthly fees or minimums, US-based customer service, and a simple, transparent digital experience designed for their needs. Charlie is transforming financial assistance for the 62+ community and providing peace of mind around their financial present and future. Charlie is not a bank, banking services provided by Sutton Bank; Member FDIC. To learn more, visit Charlie.com.
Aibidia, established in 2018, is a technology company that specializes in providing a digital transfer pricing platform designed for multinational enterprises. Its innovative platform enables organizations to enhance their transfer pricing decisions by shifting the focus from traditional document creation to value creation and actionable insights. Aibidia's solution allows companies to manage cross-border transactions and business activities effectively, leveraging data and intelligence for improved decision-making. With over 5,000 legal entities managed on its platform and an average client revenue of 7 billion euros, Aibidia is committed to transforming the way large enterprises approach cross-border business management, ultimately contributing to more strategic tax planning and operational efficiency.
Enveda Biosciences
Series B in 2023
Enveda Biosciences is a biotechnology company that employs artificial intelligence-powered tools to investigate and define molecules sourced from living organisms. Its primary objective is to build an exhaustive database of chemical biodiversity, thereby expediting the discovery of novel medicines. The company's innovative drug discovery platform integrates machine learning, metabolomics, and robotics to analyze natural samples for both chemical structure and biological activity, eliminating the need for isolating individual compounds or extensive experimentation. This enables healthcare industry clients to develop a wide range of new medications, from antibiotics to hypotensives.
Yendo is a company that offers accounting software tailored for small and medium-sized businesses. As a cloud-based application, Yendo allows users to access its features anytime and anywhere with an internet connection. The software enables users to efficiently manage invoicing, purchases, expenses, and payments, as well as track financial performance through profit and loss statements, balance sheets, and customizable reports. Based in Ireland, Yendo serves a substantial customer base in both the United Kingdom and the United States. Additionally, Yendo provides a credit card platform that offers asset-backed credit products, allowing consumers to leverage the equity in their vehicles or homes for significantly higher credit limits at competitive interest rates. This offering enables users to obtain credit without the need for traditional FICO score checks.
Fable Food Co is a company that specializes in plant-based meat alternatives, primarily utilizing shiitake mushrooms to replicate the taste and texture of traditional meat. The organization focuses on creating minimally processed, clean label products made from all-natural ingredients, catering to the growing demand for healthier and sustainable food options. Fable's offerings are widely available in major Australian grocery chains such as Harris Farm Markets, Coles, and Woolworths, as well as through meal delivery services like Marley Spoon and Dinnerly. Additionally, its products can be found on various restaurant menus across Australia, Singapore, and the UK, making them accessible to a diverse range of consumers seeking vegan substitutes for meat dishes.
Enveda Biosciences
Series B in 2022
Enveda Biosciences is a biotechnology company that employs artificial intelligence-powered tools to investigate and define molecules sourced from living organisms. Its primary objective is to build an exhaustive database of chemical biodiversity, thereby expediting the discovery of novel medicines. The company's innovative drug discovery platform integrates machine learning, metabolomics, and robotics to analyze natural samples for both chemical structure and biological activity, eliminating the need for isolating individual compounds or extensive experimentation. This enables healthcare industry clients to develop a wide range of new medications, from antibiotics to hypotensives.
Strand Therapeutics
Series A in 2022
Strand Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, that specializes in genetically programming mRNA to deliver innovative therapies aimed at enhancing patient outcomes. Founded in 2017, the company develops mRNA programming technology that allows for precise control over the location, timing, and intensity of therapeutic protein expression within the body. By employing mRNA-encoded logic circuits, Strand Therapeutics can achieve cell-type specific expression by detecting unique miRNA signatures and modulating protein dosage in response to externally administered small molecules. The company focuses on creating gene therapies powered by synthetic biology, including immunotherapies designed to enable cells to produce target cancer-killing proteins, thereby strengthening the body's immune response against cancer.
Galileo.ai is a technology company specializing in AI application management. It offers a suite of services including development, testing, monitoring, and security for AI applications. The core product is an AI platform designed to enhance machine learning processes by automatically identifying errors and data gaps, thereby improving efficiencies, reducing costs, and mitigating biases across various industries such as healthcare, finance, and insurance.
LatticeFlow
Series A in 2022
LatticeFlow is a developer of system management software focused on enabling organizations to build and deploy artificial intelligence models that are safe, reliable, and trustworthy. The company's software offers a core programming API within a new asynchronous data coordination framework, facilitating the testing and certification of machine learning systems. This approach ensures that AI models function as intended and are prepared for production use. By providing tools that enhance the robustness and transparency of AI applications, LatticeFlow empowers clients to effectively integrate artificial intelligence into their operations.
Astra, Inc., established in 2016 and based in Menlo Park, California, specializes in budgeting automation. Its platform connects to users' bank accounts, providing personalized financial recommendations and enabling automated money transfers or notifications based on user-defined rules and triggers.
Oneleet
Venture Round in 2022
Oneleet is a developer of a comprehensive cybersecurity platform aimed at helping businesses prevent cyber attacks. The company offers scalable manual cybersecurity testing as a service, delivered by vetted expert penetration testers. Utilizing artificial intelligence, Oneleet combines automated assessments with expert manual testing, providing a web asset scanner and compliance checker. This integration allows organizations to seamlessly incorporate security testing into their cybersecurity lifecycle, enhancing their overall defense against potential threats.
X1 is a financial services company that offers an innovative credit card designed to enhance the shopping experience. The X1 Card is crafted from stainless steel and features advanced technology that allows for smart credit limits and an attractive rewards program. Cardholders can earn points for every purchase, which can be redeemed for various benefits. The card is backed by Visa Signature, giving users access to over 46 million merchants globally. Co-founded by former Twitter employees Deepak Rao and Siddharth Batra, X1 has attracted notable investors, including PayPal co-founder Max Levchin and others with significant experience in technology and finance. Through its unique offerings, X1 aims to transform traditional credit card usage and improve the way consumers shop and spend.
Xilis, Inc. is a biotechnology company founded in 2019 and based in Chapel Hill, North Carolina. The company specializes in developing next-generation organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. Its flagship platform, XilisµO, facilitates rapid diagnostics, personalized drug screening, and the creation of scalable patient-derived models, which support high-throughput drug discovery. By enabling both physicians and pharmaceutical companies to conduct tailored drug screenings, Xilis aims to lower costs and improve treatment outcomes for cancer patients.
Manifold Bio
Series A in 2022
Manifold Biotechnologies, Inc. is a biotechnology company that specializes in developing platforms for the pharmacological measurement of various therapeutic protein variants. By integrating DNA technologies with machine learning, the company aims to create protein drugs that address challenging diseases. Manifold Bio's innovative approach includes a protein barcoding platform designed to enable multiplexed quantitation of protein therapeutics, thereby generating extensive data that enhances the drug development process. Founded in 2019 and located in Allston, Massachusetts, the company is focused on advancing measurement-driven design in the field of protein therapeutics.
Guild Education
Series F in 2022
Guild Education, Inc. is an educational technology company founded in 2015 and headquartered in Denver, Colorado. The company provides a lifelong learning platform designed for working adults, offering a range of online courses, workshops, and educational programs. These include bachelor’s and master’s degrees, high school diplomas, certificate programs, and language learning opportunities. Guild Education supports its users throughout their educational journey by utilizing a technology platform that facilitates discovery and learning, as well as a tech-enabled student advising model to enhance the overall experience. The company aims to empower adults to advance their education and career paths effectively.
Flexport, established in 2013, is a San Francisco-based company specializing in global freight forwarding and customs brokerage services. It offers an online platform that simplifies and streamlines international trade for businesses. Flexport's services include customs clearance, freight transportation by ocean, air, and road, along with value-added services such as cargo insurance, warehousing, and trade finance. The company's user-friendly dashboard enables clients to understand, purchase, manage, and track these services in real-time, optimizing their supply chain and logistics operations.
Monarch Money is a subscription-based platform that provides a personal finance program to track expenses. The platform aims to help consumers plan and manage their financial lives and adds all the transactions, across all bank accounts and credit cards, into one list, and creates a budget to understand where the money is going.